Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Total Voting Rights

31 Mar 2020 07:00

RNS Number : 1226I
Versarien PLC
31 March 2020
 

31 March 2020

Versarien Plc

("Versarien", the "Company" or the "Group")

Total Voting Rights

Versarien plc (AIM: VRS), the advanced materials engineering group, announces, that that in conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA"), the Company's issued share capital consists of 169,682,290 Ordinary Shares of 1p each with full voting rights.

The figure of 169,682,290 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

+44 (0)1242 269 122

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Ewan Leggat, Soltan Tagiev

+44 (0)20 3470 0470

 

Berenberg (Joint Broker)

Mark Whitmore, Simon Cardron

+44 (0) 20 3207 7800

 

Yellow Jersey (Investor Relations) 

Charles Goodwin

Georgia Colkin

Henry Wilkinson

+44 (0)20 3004 9512

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRKKKBQABKDDNN
Date   Source Headline
12th Dec 20249:59 amRNSHolding(s) in Company
11th Dec 20241:21 pmRNSHolding(s) in Company
4th Dec 20247:00 amRNS-RInvestor Presentation
27th Nov 20244:45 pmRNSHolding(s) in Company
26th Nov 20243:42 pmRNSHolding(s) in Company
21st Nov 202411:12 amRNSUpdate on Legal Claims
4th Nov 202412:07 pmRNSHolding(s) in Company
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 202410:36 amRNSUpdate on Sale of Korean Assets
31st Oct 202410:14 amRNSHolding(s) in Company
18th Oct 202410:41 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSPlacing to raise £450,000
4th Oct 20247:00 amRNSCorporate Update
30th Sep 20247:00 amRNSDisposal of AAC Cyroma Limited
14th Aug 20247:00 amRNS3D Construction Printing Contract
5th Aug 20241:16 pmRNSHolding(s) in Company
2nd Aug 202410:48 amRNSUpdate on Sale of Korean Assets
31st Jul 20242:30 pmRNSTotal Voting Rights
29th Jul 20241:47 pmRNSHolding(s) in Company
24th Jul 20247:00 amRNSPlacing to raise £550,000
18th Jul 20247:00 amRNSUpdate on Legal Claims
17th Jul 20247:00 amRNSConversion of Gnanomat Loan
6th Jun 20247:00 amRNSInterim Results for six months ended 31 March 2024
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.